BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36721766)

  • 21. Local RANKL delivery improves socket healing in bisphosphonate treated rats.
    Soundia A; Hadaya D; Chau Y; Gkouveris I; Bezouglaia O; Dry S; Pirih F; Aghaloo T; Tetradis S
    Bone; 2021 Jul; 148():115945. PubMed ID: 33836308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
    Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
    Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies.
    AlRowis R; Aldawood A; AlOtaibi M; Alnasser E; AlSaif I; Aljaber A; Natto Z
    Saudi Dent J; 2022 Mar; 34(3):202-210. PubMed ID: 35935720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
    J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
    Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis.
    Gaudin E; Seidel L; Bacevic M; Rompen E; Lambert F
    J Clin Periodontol; 2015 Oct; 42(10):922-32. PubMed ID: 26362756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients.
    Jung S; Kim J; Park JH; Kim KY; Kim HJ; Park W
    Sci Rep; 2022 May; 12(1):8641. PubMed ID: 35606457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients.
    Morishita K; Soutome S; Otsuru M; Hayashida S; Murata M; Sasaki M; Takagi Y; Sumi M; Umeda M
    Sci Rep; 2022 Jul; 12(1):11545. PubMed ID: 35799050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?
    Ueda N; Nakashima C; Aoki K; Shimotsuji H; Nakaue K; Yoshioka H; Kurokawa S; Imai Y; Kirita T
    Clin Oral Investig; 2021 May; 25(5):3087-3093. PubMed ID: 33057886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
    J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication related osteonecrosis of the jaw in osteoporotic
    Walton K; Grogan TR; Eshaghzadeh E; Hadaya D; Elashoff DA; Aghaloo TL; Tetradis S
    Dentomaxillofac Radiol; 2019 Jan; 48(1):20180128. PubMed ID: 29952657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw.
    Shin JW; Kim JE; Huh KH; Yi WJ; Heo MS; Lee SS; Choi SC
    Sci Rep; 2024 Apr; 14(1):8744. PubMed ID: 38627515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center.
    Hajeri S; Alturkistany Y
    Saudi Dent J; 2022 Sep; 34(6):479-484. PubMed ID: 36092518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Retrospective Data Analysis for the Risk Evaluation of the Development of Drug-Associated Jaw Necrosis through Dentoalveolar Interventions.
    Buchbender M; Bauerschmitz C; Pirkl S; Kesting MR; Schmitt CM
    Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35410020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study.
    Soares AL; Simon S; Gebrim LH; Nazário ACP; Lazaretti-Castro M
    Support Care Cancer; 2020 May; 28(5):2265-2271. PubMed ID: 31468192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.
    Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S
    J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ineffectiveness of Antiresorptive Agent Drug Holidays in Osteoporosis Patients for Treatment of Medication-Related Osteonecrosis of the Jaw: Consideration from Immunohistological Observation of Osteoclast Suppression and Treatment Outcomes.
    Omori K; Otsuru M; Morishita K; Hayashida S; Suyama K; Naruse T; Soutome S; Umeda M
    Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M; Kuroshima S; Sawase T
    Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.